Andrzej Jakubowiak, MD, PhD
Director, Myeloma Program
University of Chicago Medical Center
Dr. Andrzej Jakubowiak received both his medical degree and his PhD from the Medical Academy in Poznan, Poland, where he also completed an internship and residency. He then completed a postdoctoral fellowship in obstetrics and gynecology, as well as residencies in pathology and internal medicine at The University of Texas Medical School, Houston. Dr. Jakubowiak is currently professor of medicine, and director of the myeloma program at the University of Chicago Medical Center.
An internationally known expert on multiple myeloma, a cancer of the plasma cells in bone marrow, Dr. Jakubowiak works closely with the Multiple Myeloma Research Consortium (MMRC) to bring the latest treatments to the patient’s bedside as quickly as possible. His primary research focus is in the development of new drugs for the treatment of multiple myeloma. Dr. Jakubowiak has presented these research findings at medical meetings around the world and has published numerous peer-reviewed articles and book chapters. He serves as an ad hoc reviewer for several scientific journals, including the Journal of Clinical Oncology, Blood and Leukemia and Lymphoma. Dr. Jakubowiak is currently the lead investigator on a number of multi-site clinical trials for patients who are newly diagnosed, have relapsed, or have refractory (resistant to treatment) disease.
Dr. Andrzej Jakubowiak has received honoraria related to formal advisory activities from Bristol-Myers Squibb, Celgene Corporation, Millennium Pharmaceuticals, Inc. (A wholly-owned subsidiary of Takeda Pharmaceutical Company Limited), and Onyx, as well as speakers’ bureau activities from Celgene.